TotalMarketCap

abrdn Life Sciences Investors

HQLNYSE United StatesFinanceInvestment Managers

Market cap

$445.028 M

$17.33 -5.61%

Close of 6 Nov 2026

As of 6 Nov 2026, abrdn Life Sciences Investors (HQL) has a market capitalization of $445.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Investment Managers, ranked by market cap

All 83 →
  1. #58First Trust High Yield Opportunities 2027 Term FundFTHY$474.0M
  2. #59NoahNOAH$465.0M
  3. #60abrdn Life Sciences InvestorsHQL$445.0M
  4. #61Tortoise Energy InfrastructureTYG$425.1M
  5. #62Value LineVALU$399.9M

What if abrdn Life Sciences Investors were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,099,582

Per share 63,450× higher

Bitcoin $1.53T

$59,496.48

Per share 3,433× higher

Apple $5.02T

$195,321.41

Per share 11,271× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for abrdn Life Sciences Investors are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.